JPS62155286A - セフアロスポリン誘導体、その製造法及びこれを含有する抗菌性製薬組成物 - Google Patents

セフアロスポリン誘導体、その製造法及びこれを含有する抗菌性製薬組成物

Info

Publication number
JPS62155286A
JPS62155286A JP61280947A JP28094786A JPS62155286A JP S62155286 A JPS62155286 A JP S62155286A JP 61280947 A JP61280947 A JP 61280947A JP 28094786 A JP28094786 A JP 28094786A JP S62155286 A JPS62155286 A JP S62155286A
Authority
JP
Japan
Prior art keywords
alkyl
formula
alkoxy
amino
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP61280947A
Other languages
English (en)
Japanese (ja)
Inventor
ジヤン・クロード・アーノルド
ジヤン・ジヤツク・ローマン
ジヨルジユ・パスケ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca SAS
Original Assignee
ICI Pharma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ICI Pharma SA filed Critical ICI Pharma SA
Publication of JPS62155286A publication Critical patent/JPS62155286A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/38—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
    • C07D501/46—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof with the 7-amino radical acylated by carboxylic acids containing hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
JP61280947A 1985-11-27 1986-11-27 セフアロスポリン誘導体、その製造法及びこれを含有する抗菌性製薬組成物 Pending JPS62155286A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP85402331.4 1985-11-27
EP85402331 1985-11-27

Publications (1)

Publication Number Publication Date
JPS62155286A true JPS62155286A (ja) 1987-07-10

Family

ID=8194555

Family Applications (1)

Application Number Title Priority Date Filing Date
JP61280947A Pending JPS62155286A (ja) 1985-11-27 1986-11-27 セフアロスポリン誘導体、その製造法及びこれを含有する抗菌性製薬組成物

Country Status (16)

Country Link
US (1) US5013731A (fr)
EP (1) EP0225182B1 (fr)
JP (1) JPS62155286A (fr)
AT (1) ATE85616T1 (fr)
AU (1) AU585091B2 (fr)
DE (1) DE3687740T2 (fr)
DK (1) DK571786A (fr)
FI (1) FI864836A (fr)
GB (1) GB8626245D0 (fr)
HU (1) HU196813B (fr)
IE (1) IE862914L (fr)
IL (1) IL80623A0 (fr)
NO (1) NO864746D0 (fr)
NZ (1) NZ218404A (fr)
PT (1) PT83816B (fr)
ZA (1) ZA868506B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5491139A (en) * 1988-10-24 1996-02-13 The Procter & Gamble Company Antimicrobial quinolonyl lactams
US5328908A (en) * 1988-10-24 1994-07-12 Procter & Gamble Pharmaceuticals, Inc. Antimicrobial quinolone thioureas
CA2001203C (fr) * 1988-10-24 2001-02-13 Thomas P. Demuth, Jr. Dithiocarbamoyl quinolones antimicrobiens
US5180719A (en) * 1988-10-24 1993-01-19 Norwich Eaton Pharmaceuticals, Inc. Antimicrobial quinolonyl lactam esters
US5273973A (en) * 1988-10-24 1993-12-28 Norwich Eaton Pharmaceuticals, Inc. Antimicrobial quinolonyl esters
EP0366189A3 (fr) * 1988-10-24 1992-01-02 Norwich Eaton Pharmaceuticals, Inc. Lactames-quinolones antimicrobiennes
EP0525057B1 (fr) * 1990-04-18 2000-06-14 Procter & Gamble Pharmaceuticals, Inc. Quinolonyle lactames anti-microbiens
JP6027610B2 (ja) 2011-07-19 2016-11-16 インフィニティー ファーマシューティカルズ， インコーポレイテッド 複素環式化合物及びその使用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4138555A (en) * 1971-05-14 1979-02-06 Glaxo Laboratories, Limited (6R,7R)-7-[2-aryl-2-(etherified oximino)acetamido]-3-carbamoyloxymethylceph-3-em-4-carboxylic acid 1-oxides
US4033950A (en) * 1971-05-14 1977-07-05 Glaxo Laboratories Limited 3-Hydroxymethyl-7β-(2-alkoxy-or benzyloxyimino-2-arylacetamido)ceph-3-em-4-carboxylic acids and salts thereof
US4024133A (en) * 1971-05-14 1977-05-17 Glaxo Laboratories Limited 7β-[2-Etherified oximino-2-(thienyl-,furyl- or pyridylacetamido)]cephalosporins
DE2714880A1 (de) * 1977-04-02 1978-10-26 Hoechst Ag Cephemderivate und verfahren zu ihrer herstellung
SE448379B (sv) * 1978-03-31 1987-02-16 Roussel Uclaf O-substituerade oximderivat av 7-amino-tiazolyl-acetamidocefalosporansyra
DK145579A (da) * 1979-04-09 1980-10-10 Novo Industri As Fremgangsmaade til fremstilling af cephalosporinderivater
JPS56127389A (en) * 1980-02-11 1981-10-06 Squibb & Sons Inc 7-((2-amino-4-thiazolyl)(carboxy(alkylthio) alkoxyimino)acetamido)cephalosporins
US4252802A (en) * 1980-03-13 1981-02-24 E. R. Squibb & Sons, Inc. Hydroxamic acid derivatives of 7-[(2-amino-4-thiazolyl)-oximino] cephalosporins
GB2071664B (en) * 1980-03-14 1984-03-21 Squibb & Sons Inc Phosphonic acid derivatives of 7-(2-amino-4- thiazolyl)oximino) cephalosporins
JPS6011917B2 (ja) * 1981-04-09 1985-03-28 山之内製薬株式会社 新規なセファロスポリン化合物
GB2103205A (en) * 1981-06-15 1983-02-16 Fujisawa Pharmaceutical Co New cephem compounds
SU1169542A3 (ru) * 1981-09-08 1985-07-23 Эли Лилли Энд Компани (Фирма) Способ получени тиенопиридиний- или фуропиридиний-замещенных производных цефалоспорина
DE3207840A1 (de) * 1982-03-04 1983-09-15 Hoechst Ag, 6230 Frankfurt "cephalosporinderivate und verfahren zu ihrer herstellung"
GB8413152D0 (en) * 1983-06-03 1984-06-27 Ici Pharma Cephalosporin derivatives
FI851934L (fi) * 1984-05-30 1985-12-01 Ici Plc Kefalosporinderivat.
AU586229B2 (en) * 1985-04-01 1989-07-06 Mochida Pharmaceutical Co., Ltd. Cephalosporin derivatives

Also Published As

Publication number Publication date
HU196813B (en) 1989-01-30
PT83816A (en) 1986-12-01
FI864836A (fi) 1987-05-28
DE3687740T2 (de) 1993-05-27
PT83816B (pt) 1989-06-30
NO864746D0 (no) 1986-11-26
GB8626245D0 (en) 1986-12-03
DK571786A (da) 1987-05-28
EP0225182B1 (fr) 1993-02-10
ZA868506B (en) 1987-07-29
AU585091B2 (en) 1989-06-08
US5013731A (en) 1991-05-07
EP0225182A3 (en) 1988-12-14
DE3687740D1 (de) 1993-03-25
ATE85616T1 (de) 1993-02-15
DK571786D0 (da) 1986-11-27
AU6514586A (en) 1987-06-04
IE862914L (en) 1987-05-27
HUT43078A (en) 1987-09-28
EP0225182A2 (fr) 1987-06-10
IL80623A0 (en) 1987-02-27
NZ218404A (en) 1990-01-29
FI864836A0 (fi) 1986-11-27

Similar Documents

Publication Publication Date Title
BRPI0620643A2 (pt) compostos de heterocìclicos condensados úteis como inibidores de dpp-iv, formulações farmacêuticas, produtos e usos dos compostos
NZ225533A (en) Cephalosporin derivatives: processes for preparation, intermediates and pharmaceutical compositions
JP2023511337A (ja) ピリミジン－４（３ｈ）－オンヘテロ環式化合物、その調製方法、およびその医薬的使用
EP0164944B1 (fr) Dérivés de céphalosporine
JPS62155286A (ja) セフアロスポリン誘導体、その製造法及びこれを含有する抗菌性製薬組成物
GB2105334A (en) Cephalosporin isoquinolinium betaines
SK150397A3 (en) 7-acylamino-3-(imino)methyl cephalosporins, preparation method thereof, intermediates for their preparation and pharmaceutical composition containing the same
CS199714B2 (en) Process for preparing heteromonocyclic and heterobicyclic derivatives of unsaturated 7-acylamido-3-cephem-4-carboxylic acids
EP0304155B1 (fr) Dérivés de céphalosporine, procédé pour leur préparation et leurs compositions pharmaceutiques
WO2003011396A1 (fr) Derives de tetrahydroindolone et de purine lies a des arylpiperazines
JPS61178989A (ja) セフアロスポリン誘導体、その製造法及びこれを含有する抗菌性製薬組成物
US4868173A (en) Cephalosporin derivatives
KR970005844B1 (ko) 새로운 세파로스포린 화합물 및 항균제
EP0272827A2 (fr) 3-Hétérocycliquethiométhyl céphalosporines
JP2019522651A (ja) タンパク質キナーゼ阻害剤としての置換されているピロロ［２，３−ｄ］ピリダジン−４−オン及びピラゾロ［３，４−ｄ］ピリダジン−４−オン
US5053500A (en) Intermediates for the preparation of beta-lactam antibiotics
JPS6097984A (ja) セフエム誘導体、その製造方法および医薬組成物
JPWO2014104148A1 (ja) セフェム化合物
EP0300665B1 (fr) Dérivés de céphalosporine, procédé pour leur préparation et leurs compositions pharmaceutiques
US5412093A (en) 3-heterocyclic thiomethyl cephalosporins
JPS63301887A (ja) セフアロスポリン化合物、その製造法及びこれを含有し抗菌作用を有する製薬組成物
JPS59231091A (ja) ７−オキソ−４−チア−１−アザビシクロ〔３．２．０〕ヘプタ−２−エン誘導体
JP2002514650A (ja) 新規なセファロスポリン化合物、その製造方法およびそれを含有する抗菌性組成物
AU768520B2 (en) Triazolopurine derivatives, drug compositions containing the same and adenosine A3 receptor affinitive agents
JPS58116488A (ja) セフアロスポリン誘導体、その製法及びこの化合物を含む抗菌作用を有する医薬組成物